Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.69 USD | -0.85% | -4.09% | -28.40% |
May. 13 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
May. 08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.40% | 198M | |
+15.58% | 79.03B | |
+10.49% | 8.96B | |
-10.76% | 5.19B | |
+54.31% | 4.77B | |
+11.19% | 4.26B | |
-22.37% | 2.37B | |
+12.49% | 2.3B | |
-30.09% | 2.21B | |
+20.63% | 2.17B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Zevra Therapeutics Says Phase 2 Trial of Idiopathic Hypersomnia Treatment Fulfilled Objectives